Literature DB >> 21435443

Interleukin-1 receptor-mediated inflammation impairs the heat shock response of human mesothelial cells.

Klaus Kratochwill1, Michael Lechner, Anton Michael Lichtenauer, Rebecca Herzog, Hans Christian Lederhuber, Christian Siehs, Michaela Endemann, Bernd Mayer, Andreas Rizzi, Christoph Aufricht.   

Abstract

Bioincompatibility of peritoneal dialysis fluids (PDF) limits their use in renal replacement therapy. PDF exposure harms mesothelial cells but induces heat shock proteins (HSP), which are essential for repair and cytoprotection. We searched for cellular pathways that impair the heat shock response in mesothelial cells after PDF-exposure. In a dose-response experiment, increasing PDF-exposure times resulted in rapidly increasing mesothelial cell damage but decreasing HSP expression, confirming impaired heat shock response. Using proteomics and bioinformatics, simultaneously activated apoptosis-related and inflammation-related pathways were identified as candidate mechanisms. Testing the role of sterile inflammation, addition of necrotic cell material to mesothelial cells increased, whereas addition of the interleukin-1 receptor (IL-1R) antagonist anakinra to PDF decreased release of inflammatory cytokines. Addition of anakinra during PDF exposure resulted in cytoprotection and increased chaperone expression. Thus, activation of the IL-1R plays a pivotal role in impairment of the heat shock response of mesothelial cells to PDF. Danger signals from injured cells lead to an elevated level of cytokine release associated with sterile inflammation, which reduces expression of HSP and other cytoprotective chaperones and exacerbates PDF damage. Blocking the IL-1R pathway might be useful in limiting damage during peritoneal dialysis.
Copyright © 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21435443      PMCID: PMC3078451          DOI: 10.1016/j.ajpath.2010.12.034

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  46 in total

1.  A proteomic view on the role of glucose in peritoneal dialysis.

Authors:  Michael Lechner; Klaus Kratochwill; Anton Lichtenauer; Pavel Rehulka; Bernd Mayer; Christoph Aufricht; Andreas Rizzi
Journal:  J Proteome Res       Date:  2010-05-07       Impact factor: 4.466

2.  Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels.

Authors:  A Shevchenko; M Wilm; O Vorm; M Mann
Journal:  Anal Chem       Date:  1996-03-01       Impact factor: 6.986

3.  Peritoneal dialysis solution induces apoptosis of mesothelial cells.

Authors:  A H Yang; J Y Chen; Y P Lin; T P Huang; C W Wu
Journal:  Kidney Int       Date:  1997-04       Impact factor: 10.612

4.  Small stress proteins as novel regulators of apoptosis. Heat shock protein 27 blocks Fas/APO-1- and staurosporine-induced cell death.

Authors:  P Mehlen; K Schulze-Osthoff; A P Arrigo
Journal:  J Biol Chem       Date:  1996-07-12       Impact factor: 5.157

5.  Peritoneal dialysate fluid composition determines heat shock protein expression patterns in human mesothelial cells.

Authors:  K Arbeiter; B Bidmon; M Endemann; T O Bender; O Eickelberg; D Ruffingshofer; T Mueller; H Regele; K Herkner; C Aufricht
Journal:  Kidney Int       Date:  2001-11       Impact factor: 10.612

Review 6.  Decoding dangerous death: how cytotoxic chemotherapy invokes inflammation, immunity or nothing at all.

Authors:  R G van der Most; A J Currie; B W S Robinson; R A Lake
Journal:  Cell Death Differ       Date:  2007-11-16       Impact factor: 15.828

7.  In vitro effects of bicarbonate and bicarbonate-lactate buffered peritoneal dialysis solutions on mesothelial and neutrophil function.

Authors:  N Topley; D Kaur; M M Petersen; A Jörres; J D Williams; D Faict; C J Holmes
Journal:  J Am Soc Nephrol       Date:  1996-02       Impact factor: 10.121

8.  Insulin Signaling, GSK-3, Heat Shock Proteins and the Natural History of Type 2 Diabetes Mellitus: A Hypothesis.

Authors:  Philip L Hooper
Journal:  Metab Syndr Relat Disord       Date:  2007-09       Impact factor: 1.894

Review 9.  Stress induction of GRP78/BiP and its role in cancer.

Authors:  Jianze Li; Amy S Lee
Journal:  Curr Mol Med       Date:  2006-02       Impact factor: 2.222

10.  Glucose degradation products increase apoptosis of human mesothelial cells.

Authors:  Alessandro Amore; Giorgio Cappelli; Paola Cirina; Giovanni Conti; Caterina Gambaruto; Leandra Silvestro; Rosanna Coppo
Journal:  Nephrol Dial Transplant       Date:  2003-04       Impact factor: 5.992

View more
  10 in total

1.  A method to resolve the composition of heterogeneous affinity-purified protein complexes assembled around a common protein by chemical cross-linking, gel electrophoresis and mass spectrometry.

Authors:  Elena L Rudashevskaya; Roberto Sacco; Klaus Kratochwill; Marie L Huber; Matthias Gstaiger; Giulio Superti-Furga; Keiryn L Bennett
Journal:  Nat Protoc       Date:  2012-12-13       Impact factor: 13.491

2.  Modulation of cellular stress response via the erythropoietin/CD131 heteroreceptor complex in mouse mesenchymal-derived cells.

Authors:  Stefan Bohr; Suraj J Patel; Radovan Vasko; Keyue Shen; Arvin Iracheta-Vellve; Jungwoo Lee; Shyam Sundhar Bale; Nilay Chakraborty; Michael Brines; Anthony Cerami; Francois Berthiaume; Martin L Yarmush
Journal:  J Mol Med (Berl)       Date:  2014-11-06       Impact factor: 4.599

3.  Addition of Alanyl-Glutamine to Dialysis Fluid Restores Peritoneal Cellular Stress Responses - A First-In-Man Trial.

Authors:  Klaus Kratochwill; Michael Boehm; Rebecca Herzog; Katharina Gruber; Anton Michael Lichtenauer; Lilian Kuster; Dagmar Csaicsich; Andreas Gleiss; Seth L Alper; Christoph Aufricht; Andreas Vychytil
Journal:  PLoS One       Date:  2016-10-21       Impact factor: 3.240

Review 4.  Is there such a thing as biocompatible peritoneal dialysis fluid?

Authors:  Claus Peter Schmitt; Christoph Aufricht
Journal:  Pediatr Nephrol       Date:  2016-10-08       Impact factor: 3.714

5.  Functional and Transcriptomic Characterization of Peritoneal Immune-Modulation by Addition of Alanyl-Glutamine to Dialysis Fluid.

Authors:  Rebecca Herzog; Lilian Kuster; Julia Becker; Tobias Gluexam; Dietmar Pils; Andreas Spittler; Manoj K Bhasin; Seth L Alper; Andreas Vychytil; Christoph Aufricht; Klaus Kratochwill
Journal:  Sci Rep       Date:  2017-07-24       Impact factor: 4.379

6.  Effects of Alanyl-Glutamine Treatment on the Peritoneal Dialysis Effluent Proteome Reveal Pathomechanism-Associated Molecular Signatures.

Authors:  Rebecca Herzog; Michael Boehm; Markus Unterwurzacher; Anja Wagner; Katja Parapatics; Peter Májek; André C Mueller; Anton Lichtenauer; Keiryn L Bennett; Seth L Alper; Andreas Vychytil; Christoph Aufricht; Klaus Kratochwill
Journal:  Mol Cell Proteomics       Date:  2017-12-04       Impact factor: 5.911

Review 7.  Preventing Peritoneal Dialysis-Associated Fibrosis by Therapeutic Blunting of Peritoneal Toll-Like Receptor Activity.

Authors:  Anne-Catherine Raby; Mario O Labéta
Journal:  Front Physiol       Date:  2018-11-27       Impact factor: 4.566

8.  Senescence-Associated Changes in Proteome and O-GlcNAcylation Pattern in Human Peritoneal Mesothelial Cells.

Authors:  Rebecca Herzog; Silvia Tarantino; András Rudolf; Christoph Aufricht; Klaus Kratochwill; Janusz Witowski
Journal:  Biomed Res Int       Date:  2015-11-10       Impact factor: 3.411

9.  Cross-omics comparison of stress responses in mesothelial cells exposed to heat- versus filter-sterilized peritoneal dialysis fluids.

Authors:  Klaus Kratochwill; Thorsten O Bender; Anton M Lichtenauer; Rebecca Herzog; Silvia Tarantino; Katarzyna Bialas; Achim Jörres; Christoph Aufricht
Journal:  Biomed Res Int       Date:  2015-10-01       Impact factor: 3.411

Review 10.  Proteomic Research in Peritoneal Dialysis.

Authors:  Mario Bonomini; Francesc E Borras; Maribel Troya-Saborido; Laura Carreras-Planella; Lorenzo Di Liberato; Arduino Arduini
Journal:  Int J Mol Sci       Date:  2020-07-31       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.